Characterization of the novel anti-TNF-α single-chain fragment antibodies using experimental and computational approaches

References

• (a) Griffiths, A.D.; Duncan, A.R. Strategies for Selection of Antibodies by Phage Display. Curr. Opin. Biotechnol. 1998, 9, 102–108.
   PubMed Web of Science ®Google Scholar
  (b) Hudson, P.J. Recombinant Antibody Fragments. Curr. Opin. Biotechnol. 1998, 9, 395–402.
   PubMed Web of Science ®Google Scholar
  (c) Hudson, P.J. Recombinant Antibody Constructs in Cancer Therapy. Curr. Opin. Immunol. 1999, 11, 548–557.
   PubMed Web of Science ®Google Scholar
  (d) Little, M.; Kipriyanov, S.M.; Le Gall, F.; Moldenhauer, G. Of Mice and Men: Hybridoma and Recombinant Antibodies. Immunol. Today 2000, 21, 364–370.
   PubMedGoogle Scholar
• (a) Jain, S.; Aresu, L.; Comazzi, S.; Shi, J.; Worrall, E.; Clayton, J.; Humphries, W.; Hemmington, S.; Davis, P.; Murray, E.; et al. The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine. PLoS ONE. 2016, 11, e0148366.
   PubMed Web of Science ®Google Scholar
  (b) Nelson, A.L. Antibody Fragments: Hope and Hype. mAbs. 2010, 2, 77–83.
   PubMed Web of Science ®Google Scholar
• Saeed, A.F.; Wang, R.; Ling, S.; Wang, S. Antibody Engineering for Pursuing a Healthier Future. Front. Microbiol. 2017, 8, 495.
   PubMed Web of Science ®Google Scholar
• Esposito, E.; Cuzzocrea, S. TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, Ischemia-Reperfusion Injury and Trauma. Curr. Med. Chem. 2009, 16, 3152–3167.
   PubMed Web of Science ®Google Scholar
• Carswell, E.A.; Old, L.J.; Kassel, R.L.; Green, S.; Fiore, N.; Williamson, B. An Endotoxin Induced Serum Factor That Cuases Necrosis of Tumors. Proc. Natl. Acad. Sci. USA. 1975, 72, 3666–3670.
   PubMed Web of Science ®Google Scholar
• (a) Idriss, H.T.; Naismith, J.H. TNFα and the TNF Receptor Superfamily: Structure-Function Relationship(s). Microsc. Res. Tech. 2000, 50, 184–195.
   PubMed Web of Science ®Google Scholar
  (b) Moss, M.L.; Sklair-Tavron, L.; Nudelman, R. Drug Insight: Tumor Necrosis Factor-Converting Enzyme as a Pharmaceutical Target for Rheumatoid Arthritis. Nat. Clin. Pract. Rheumatol. 2008, 4, 300–309.
   PubMedGoogle Scholar
• (a) Keller, M.; Mazuch, J.; Abraham, U.; Eom, G.D.; Herzog, E.D.; Volk, H.D.; Kramer, A.; Maier, B. A Circadian Clock in Macrophages Controls Inflammatory Immune Responses. Proc. Natl. Acad. Sci. USA. 2009, 106, 21407–21412.
   PubMed Web of Science ®Google Scholar
  (b) Scheiermann, C.; Kunisaki, Y.; Frenette, P.S. Circadian Control of the Immune System. Nat. Rev. Immunol. 2013, 13, 190–198.
   PubMed Web of Science ®Google Scholar
  (c) Kong, B.W.; Lee, J.; Bottje, W.G.; Lassiter, K.; Gentles, L.E.; Chandra, Y.G.; Foster, D.N. Microarray Analysis of Early and Late Passage Chicken Embryo Fibroblast Cells. Poultry Sci. 2013, 92, 770–781.
   PubMed Web of Science ®Google Scholar
  (d) Croft, M.; Benedict, C.A.; Ware, C.F. Clinical Targeting of the TNF and TNFR Superfamilies. Nat. Rev. Drug Discov. 2013, 12, 147–168.
   PubMed Web of Science ®Google Scholar
  (e) Locksley, R.M.; Killeen, N.; Lenardo, M.J. The TNF and TNF Receptor Superfamilies: Integrating Mammalian Biology. Cell. 2001, 104, 487–501.
   PubMed Web of Science ®Google Scholar
• (a) Cleynen, I.; Vermeire, S. Paradoxical Inflammation Induced by Anti-TNF Agents in Patients with IBD. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 496–503.
   PubMed Web of Science ®Google Scholar
  (b) Ricart, E.; Ordás, I.; Panés, J. Anti-TNF Antibody Therapy in Crohn's Disease: The Risk of a Switch. Gut. 2012, 61, 169–170.
   PubMed Web of Science ®Google Scholar
• (a) Monaco, C.; Nanchahal, J.; Taylor, P.; Feldmann, M. Anti-TNF Therapy: Past, Present and Future. Int. Immunol. 2015, 27, 55–62.
   PubMed Web of Science ®Google Scholar
  (b) Thalayasingam, N.; Isaacs, J.D. Anti-TNF Therapy. Best Pract. Res. Clin. Rheumatol. 2011, 25, 549–567.
   PubMed Web of Science ®Google Scholar
• (a) Jarrot, P.A.; Kaplanski, G. Anti-TNF-Alpha Therapy and Systemic Vasculitis. Mediators. Inflamm. 2014, 2014, 493593.
   PubMedGoogle Scholar
  (b) Elliott, M.J.; Maini, R.N.; Feldmann, M.; Kalden, J.R.; Antoni, C.; Smolen, J.S.; Leeb, B.; Breedveld, F.C.; Macfarlane, J.D.; Bijl, J. A.; et al. Randomised Double-Blind Comparison of Chimeric Monoclonal Antibody to Tumour Necrosis Factor α (cA2) Versus Placebo in Rheumatoid Arthritis. The Lancet. 1994, 344, 1105–1110.
   PubMed Web of Science ®Google Scholar
  (c) Palladino, M.A.; Bahjat, F.R.; Theodorakis, E.A.; Moldawer, L.L. Anti-TNF-α Therapies: The Next Generation. Nat. Rev. Drug Discov. 2003, 2, 736–746.
   PubMed Web of Science ®Google Scholar
  (d) Sandborn, W.J.; Hanauer, S.B.; Katz, S.; Safdi, M.; Wolf, D.G.; Baerg, R.D.; Tremaine, W.J.; Johnson, T.; Diehl, N.N.; Zinsmeister, A.R. Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 2001, 121, 1088–1094.
   PubMed Web of Science ®Google Scholar
  (e) Tracey, D.; Klareskog, L.; Sasso, E.H.; Salfeld, J.G.; Tak, P.P. Tumor Necrosis Factor Antagonist Mechanisms of Action: A Comprehensive Review. Pharmacol. Therapeut. 2008, 117, 244–279.
   PubMed Web of Science ®Google Scholar
• (a) Gómez-Reino, J.J.; Carmona, L.; Rodríguez Valverde, V.; Mola, E.M.; Montero, M.D. Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibitors may Predispose to Significant Increase in Tuberculosis Risk: A Multicenter Active-Surveillance Report. Arthrit. Rheumat. 2003, 48, 2122–2127.
   PubMed Web of Science ®Google Scholar
  (b) Lubel, J.S.; Testro, A.G.; Angus, P.W. Hepatitis B Virus Reactivation Following Immunosuppressive Therapy: Guidelines for Prevention and Management. Intern. Med. J. 2007, 37, 705–712.
   PubMed Web of Science ®Google Scholar
  (c) Nyboe Andersen, N.; Pasternak, B.; Friis-Møller, N.; Andersson, M.; Jess, T. Association Between Tumour Necrosis Factor-Α Inhibitors and Risk of Serious Infections in People with Inflammatory Bowel Disease: Nationwide Danish Cohort Study. BMJ. (Clin. Res. Ed.) 2015, 350, h2809.
   PubMedGoogle Scholar
• Ahmad, Z.A.; Yeap, S.K.; Ali, A.M.; Ho, W.Y.; Alitheen, N.B.M.; Hamid, M. ScFv Antibody: Principles and Clinical Application. Clin. Dev. Immunol. 2012, 2012, 1.
   Google Scholar
• Alizadeh, A.A.; Hamzeh-Mivehroud, M.; Dastmalchi, S. Identification of Novel Single Chain Fragment Variable Antibodies Against Tnf-α Using Phage Display Technology. Adv. Pharm. Bull. 2015, 5, 661–666.
   PubMed Web of Science ®Google Scholar
• Alizadeh, A.A.; Hamzeh-Mivehroud, M.; Farajzadeh, M.; Dastmalchi, S. Identification of Novel Peptides Against TNF-α Using Phage Display Technique and in Silico Modeling of Their Modes of Binding. Eur. J. Pharmaceut. Sci. 2017, 96, 490–498.
   PubMed Web of Science ®Google Scholar
• Pace, C.N. Determination and Analysis of Urea and Guanidine Hydrochloride Denaturation Curves. Meth. Enzymol. 1986, 131, 266–280.
   PubMedGoogle Scholar
• Alizadeh, A.A.; Hamzeh-Mivehroud, M.; Farajzadeh, M.; Moosavi-Movahedi, A.A.; Dastmalchi, S. A Simple and Rapid Method for Expression and Purification of Functional TNF-Alpha Using GST Fusion System. Curr.Pharm. Biotechnol. 2015, 16, 707–715.
   PubMed Web of Science ®Google Scholar
• Laskowski, R.A.; Rullmann, J.A.C.; MacArthur, M.W.; Kaptein, R.; Thornton, J.M. AQUA and PROCHECK-NMR: Programs for Checking the Quality of Protein Structures Solved by NMR. J. Biomol. Nmr. 1996, 8, 477–486.
   PubMed Web of Science ®Google Scholar
• Luthy, R.; Bowie, J.U.; Eisenberg, D. Assessment of Protein Models with Three-Dimensional Profiles. Nature. 1992, 356, 83.
   PubMed Web of Science ®Google Scholar
• Tina, K.; Bhadra, R.; Srinivasan, N. PIC: Protein Interactions Calculator. Nucl. Acid. Res. 2007, 35, W473–W476.
   PubMed Web of Science ®Google Scholar
• (a) Smith, G.P.; Petrenko, V.A. Phage Display. Chem. Rev. 1997, 97, 391–410.
   PubMed Web of Science ®Google Scholar
  (b) Azzazy, H.M.; Highsmith, W.E., Jr. Phage Display Technology: Clinical Applications and Recent Innovations. Clin. Biochem. 2002, 35, 425–445.
   PubMed Web of Science ®Google Scholar
  (c) Pande, J.; Szewczyk, M.M.; Grover, A.K. Phage Display: Concept, Innovations, Applications and Future. Biotechnol. Adv. 2010, 28, 849–858.
   PubMed Web of Science ®Google Scholar
• (a) Noren, K.A.; Noren, C.J. Construction of High-Complexity Combinatorial Phage Display Peptide Libraries. Methods. 2001, 23, 169–178.
   PubMed Web of Science ®Google Scholar
  (b) Sidhu, S.S.; Lowman, H.B.; Cunningham, B.C.; Wells, J.A. Phage Display for Selection of Novel Binding Peptides. Meth. Enzymol. 2000, 328, 333–363.
   PubMed Web of Science ®Google Scholar
• Bowie, J.U.; Luthy, R.; Eisenberg, D. A Method to Identify Protein Sequences That Fold into a Known Three-Dimensional Structure. Science. 1991, 253, 164–170.
   PubMed Web of Science ®Google Scholar
• (a) Melo, F.; Devos, D.; Depiereux, E.; Feytmans, E. ANOLEA: A WWW Server to Assess Protein Structures. Proc. Int. Conf. Intel. Syst. Mol. Biol. 1997, 5, 187–190.
   PubMedGoogle Scholar
  (b) Melo, F.; Feytmans, E. Assessing Protein Structures with a Non-Local Atomic Interaction Energy. J. Mol. Biol. 1998, 277, 1141–1152.
   PubMed Web of Science ®Google Scholar
• Wallner, B.; Elofsson, A. Can Correct Protein Models Be Identified? Protein Sci. 2003, 12, 1073–1086.
   PubMed Web of Science ®Google Scholar
• Rogozin, I.B.; Solovyov, V.V.; Kolchanov, N.A. Somatic Hypermutagenesis in Immunoglobulin Genes. I. Correlation between Somatic Mutations and Repeats. Somatic Mutation Properties and Clonal Selection. Biochim. Biophys. Acta. 1991, 1089, 175–182.
   PubMedGoogle Scholar
• Furrer, E.; Hulmann, V.; Urech, D.M. Intranasal Delivery of ESBA105, a TNF-Alpha-Inhibitory scFv Antibody Fragment to the Brain. J. Neuroimmunol. 2009, 215, 65–72.
   PubMed Web of Science ®Google Scholar
• Athanasios, T.; Brunner, P.M.; Kamran, G.; Claudia, B.; Karin, L.; Martin, R.; Georg, S.; Thomas, L.; Thomas, J. The Single‐Chain anti‐TNF‐α Antibody DLX105 Induces Clinical and Biomarker Responses upon Local Administration in Patients with Chronic Plaque‐Type Psoriasis. Exp. Dermatol. 2016, 25, 428–433.
   PubMedGoogle Scholar
• Ottiger, M.; Thiel, M.A.; Feige, U.; Lichtlen, P.; Urech, D.M. Efficient Intraocular Penetration of Topical anti-TNF-Alpha Single-Chain Antibody (ESBA105) to Anterior and Posterior Segment without Penetration Enhancer. Invest. Ophthalmol. Vis. Sci. 2009, 50, 779–786.
   PubMed Web of Science ®Google Scholar
• Urech, D.M.; Feige, U.; Ewert, S.; Schlosser, V.; Ottiger, M.; Polzer, K.; Schett, G.; Lichtlen, P. Anti-Inflammatory and Cartilage-Protecting Effects of an Intra-Articularly Injected Anti-TNF{Alpha} Single-Chain Fv Antibody (ESBA105) Designed for Local Therapeutic Use. Ann. Rheumat. Dis. 2010, 69, 443–449.
   PubMed Web of Science ®Google Scholar
• (a) Antoni, C.; Braun, J. Side Effects of Anti-TNF Therapy: Current Knowledge. Clin. Exp. Rheumatol. 2002, 20, S152–S157.
   PubMed Web of Science ®Google Scholar
  (b) Debandt, M.; Vittecoq, O.; Descamps, V.; Le Lot.X.; Meyer, O. Anti-TNF-?-Induced Systemic Lupus Syndrome. Clin. Rheumatol. 2003, 22, 56–61.
   PubMed Web of Science ®Google Scholar
  (c) Devos, S.A.; Van Den Bossche, N.; De Vos, M.; Naeyaert, J.M. Adverse Skin Reactions to Anti-TNF-Alpha Monoclonal Antibody Therapy. Dermatology. 2003, 206, 388–390.
   PubMed Web of Science ®Google Scholar
  (d) Dias, O.M.; Pereira, D.A.; Baldi, B.G.; Costa, A.N.; Athanazio, R.A.; Kairalla, R.A.; Carvalho, C.R. Adalimumab-Induced Acute Interstitial Lung Disease in a Patient with Rheumatoid Arthritis. J. Bras. Pneumol. 2014, 40, 77–81.
   PubMed Web of Science ®Google Scholar
  (e) Shanahan, F. Anti-TNF Therapy for Crohn's Disease: A Perspective (Infliximab is not the Drug We Have Been Waiting For). Inflamm. Bowel. Dis. 2000, 6, 137–139.
   PubMed Web of Science ®Google Scholar
  (f) Wolf, R.; Matz, H.; Orion, E.; Ruocco, V. Anti-TNF Therapies–The Hope of Tomorrow. Clin. Dermatol. 2002, 20, 522–530.
   PubMed Web of Science ®Google Scholar
• (a) Brunetti, J.; Lelli, B.; Scali, S.; Falciani, C.; Bracci, L.; Pini, A. A Novel Phage-Library-Selected Peptide Inhibits Human TNF-Alpha Binding to its Receptors. Molecules. 2014, 19, 7255–7268.
   PubMed Web of Science ®Google Scholar
  (b) Chirinos-Rojas, C.L.; Steward, M.W.; Partidos, C.D. Use of a Solid-Phase Random Peptide Library to Identify Inhibitors of TNF-Alpha Mediated Cytotoxicity In Vitro. Cytokine. 1997, 9, 226–232.
   PubMed Web of Science ®Google Scholar
  (c) Chirinos-Rojas, C.L.; Steward, M.W.; Partidos, C.D. A Peptidomimetic Antagonist of TNF-Alpha-Mediated Cytotoxicity Identified from a Phage-Displayed Random Peptide Library. J. Immunol. 1998, 161, 5621–5626.
   PubMed Web of Science ®Google Scholar
  (d) Chirinos-Rojas, C.L.; Steward, M.W.; Partidos, C.D. A Phage-Displayed Mimotope Inhibits Tumour Necrosis Factor-Alpha-Induced Cytotoxicity More Effectively Than the free mimotope. Immunology. 1999, 96, 109–113.
   PubMed Web of Science ®Google Scholar
  (e) Guo, H.P.; Luo, H.B.; Liu, Y.J.; Zhu, P.; Fu, N. Screening of Tumor Necrosis Factor-Alpha-Binding Peptides By Phage Display Peptide Library. Di Yi Jun Yi Da Xue Xue Bao. 2002, 22, 597–599.
   PubMedGoogle Scholar
  (f) Sclavons, C.; Burtea, C.; Boutry, S.; Laurent, S.; Vander Elst, L.; Muller, R.N. Phage Display Screening for Tumor Necrosis Factor- alpha -Binding Peptides: Detection of Inflammation in a Mouse Model of Hepatitis. Int. J. Pept. 2013, 2013, 348409.
   PubMedGoogle Scholar
  (g) Zhang, J.; Zheng, L.; Zhao, A.; Gao, B.; Liu, N.-L.; Wang, F.; Dong, J.; Xin, Z.-T.; Shao, N.-S.; Wang, H.-X.; et al. Identification of Anti-TNFα Peptides with Consensus Sequence. Biochem. Biophys. Res. Commun. 2003, 310, 1181–1187.
   PubMed Web of Science ®Google Scholar
  (h) Kalliolias, G.D.; Ivashkiv, L.B. TNF Biology, Pathogenic Mechanisms and Emerging Therapeutic Strategies. Nat. Rev. Rheumatol. 2016, 12, 49–62.
   PubMed Web of Science ®Google Scholar
• Okamoto, T.; Mukai, Y.; Yoshioka, Y.; Shibata, H.; Kawamura, M.; Yamamoto, Y.; Nakagawa, S.; Kamada, H.; Hayakawa, T.; Mayumi, T.; et al. Optimal Construction of Non-Immune scFv Phage Display Libraries from Mouse Bone Marrow and Spleen Established to Select Specific scFvs Efficiently Binding to Antigen. Biochem. Biophys. Res. Commun. 2004, 323, 583–591.
   PubMed Web of Science ®Google Scholar
• Yang, T.; Yang, L.; Chai, W.; Li, R.; Xie, J.; Niu, B. A Strategy for High-Level Expression of a Single-Chain Variable Fragment against TNFα by Subcloning Antibody Variable Regions from the Phage Display Vector pCANTAB 5E into pBV220. Protein. Exp. Purific. 2011, 76, 109–114.
   PubMed Web of Science ®Google Scholar
• Chen, W.; Zhang, J.; Zhang, T.; Li, H.; Wang, W.; Xia, Z.; Wang, M. Improved Isolation of anti-rhTNF-Alpha scFvs from Phage Display Library by Bioinformatics. Mol. Biotechnol. 2009, 43, 20–28.
   PubMed Web of Science ®Google Scholar
• de Wildt, R.M.; Mundy, C.R.; Gorick, B.D.; Tomlinson, I.M. Antibody Arrays for High-Throughput Screening of Antibody–Antigen Interactions. Nat. Biotechnol. 2000, 18, 989–994.
   PubMed Web of Science ®Google Scholar
• Royer, C.A.; Mann, C.J.; Matthews, C.R. Resolution of the Fluorescence Equilibrium Unfolding Profile of Trp Aporepressor Using Single Tryptophan Mutants. Protein Sci. 1993, 2, 1844–1852.
   PubMed Web of Science ®Google Scholar
• Chang, H.; Qin, W.; Li, Y.; Zhang, J.; Lin, Z.; Lv, M.; Sun, Y.; Feng, J.; Shen, B. A Novel Human scFv Fragment against TNF-Alpha from De Novo Design Method. Mol. Immunol. 2007, 44, 3789–3796.
   PubMed Web of Science ®Google Scholar
• Hu, S.; Liang, S.; Guo, H.; Zhang, D.; Li, H.; Wang, X.; Yang, W.; Qian, W.; Hou, S.; Wang, H.; et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View. J. Biol. Chem. 2013, 288, 27059–27067.
   PubMed Web of Science ®Google Scholar
• (a) Finlay, W.J.; Shaw, I.; Reilly, J.P.; Kane, M. Generation of High-Affinity Chicken Single-Chain Fv Antibody Fragments for Measurement of the Pseudonitzschia Pungens Toxin Domoic Acid. Appl. Environ. Microbiol. 2006, 72, 3343–3349.
   PubMed Web of Science ®Google Scholar
  (b) Park, S.-G.; Lee, J.-S.; Je, E.-Y.; Kim, I.-J.; Chung, J.-H.; Choi, I.-H. Affinity Maturation of Natural Antibody Using a Chain Shuffling Technique and the Expression of Recombinant Antibodies in Escherichia coli. Biochem. Biophys. Res. Commun. 2000, 275, 553–557.
   PubMed Web of Science ®Google Scholar